Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Indivior plc (INDV)
:INDV
INDV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.33 - $23.22
Previous CloseN/A
Volume129.08K
Average Volume (3M)1.17M
Market Cap
$1.15B
Enterprise Value$958.26M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Apr 24, 2025EPS Estimate
0.25Last Dividend Ex-Date
Jun 16, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding124,440,150
10 Day Avg. Volume1,278,286
30 Day Avg. Volume1,171,654
Standard Deviation0.14
R-Squared0.11
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.96
Price to Cash Flow (P/CF)20.50
P/FCF Ratio15.00
Enterprise Value/Market Cap0.83
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.06
Enterprise Value/Ebitda16.24
Forecast
1Y Price Target
$15.45Price Target Upside71.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Indivior News
PremiumCompany Announcements
Indivior’s Earnings Call: Growth Amidst Challenges---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFY24 results ahead of expectations with group sales increasing 9% to $1,188m, helped by the 20% increase in Sublocade sales.
Market PositionSublocade retains a dominant market share with approximately 80% share within the cohort for buprenorphine-based LAI and 60% share of LAI-naive patients.
Bears Say
Competitive PressureManagement commentary at two recent broker conferences has flagged ongoing transitory issues (Medicaid disenrollment) and increasing competitive headwinds (from Brixadi) to Sublocade.
---
Ownership Overview
4.98% Insiders
3.59% Mutual Funds
10.42% Other Institutional Investors
76.78% Public Companies and
Individual Investors
INDV FAQ
What was Indivior plc’s price range in the past 12 months?
Indivior plc lowest stock price was $7.33 and its highest was $23.22 in the past 12 months.
What is Indivior plc’s market cap?
Indivior plc’s market cap is $1.15B.
When is Indivior plc’s upcoming earnings report date?
Indivior plc’s upcoming earnings report date is Apr 24, 2025 which is in 61 days.
How were Indivior plc’s earnings last quarter?
Indivior plc released its earnings results on Feb 20, 2025. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.222 by $0.098.
Is Indivior plc overvalued?
According to Wall Street analysts Indivior plc’s price is currently Undervalued.
Does Indivior plc pay dividends?
Indivior plc pays a Notavailable dividend of $0.46 which represents an annual dividend yield of N/A. See more information on Indivior plc dividends here
What is Indivior plc’s EPS estimate?
Indivior plc’s EPS estimate is 0.25.
How many shares outstanding does Indivior plc have?
Indivior plc has 124,440,150 shares outstanding.
What happened to Indivior plc’s price movement after its last earnings report?
Indivior plc reported an EPS of $0.32 in its last earnings report, beating expectations of $0.222. Following the earnings report the stock price went down -17.599%.
Which hedge fund is a major shareholder of Indivior plc?
Currently, no hedge funds are holding shares in INDV
---
Indivior Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.45 (71.89% Upside)
$15.45 (71.89% Upside)
Blogger Sentiment
Bullish
INDV Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth £198.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.29%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-23.63%
Trailing 12-Months
Company Description
Indivior plc
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
---
INDV Stock 12 Month Forecast
Average Price Target
$15.45
▲(71.89% Upside)
Technical Analysis
Best Analysts Covering INDV
1 Year
1 Year Success Rate
8/24 ratings generated profit
1 Year Average Return
-25.79%
reiterated a buy rating 2 months ago
Copying James Vane's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -25.79% per trade.
---